Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report - Top-Institutions - MDSpire

Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report

  • By

  • Jonas Povilavičius

  • Geistė Tubutytė

  • Kamilė Bagdonaitė

  • Audrius Dulskas

  • Arūnas Strumila

  • Austėja Račytė

  • June 1, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Allegheny Health Network
    Allegheny Health Network

    Pittsburgh, PA

    Key Differentiators

    • Pediatric Gastroenterology

Original Source(s)

Anti-reflux mucosal ablation (ARMA) as a novel minimally invasive treatment for severe gastroesophageal reflux disease in a child: the first pediatric case report

  • by Jonas Povilavičius, Geistė Tubutytė, Kamilė Bagdonaitė, Audrius Dulskas, Arūnas Strumila, Austėja Račytė

  • June 1, 2026

Related Content

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.

Clinical utility of an evolving cholestasis gene panel in 10,000 children and adults